Quality of Life in Patients With Inflammatory Bowel Disease: Importance of Psychological Symptoms
- PMID: 36185946
- PMCID: PMC9514670
- DOI: 10.7759/cureus.28502
Quality of Life in Patients With Inflammatory Bowel Disease: Importance of Psychological Symptoms
Abstract
Background Depressive, anxiety, and stress symptoms are prevalent in patients with inflammatory bowel disease (IBD) and may negatively influence the disease course and quality of life. The study aimed to assess the relationship between psychological factors and patients' quality of life (QoL). Materials and methods A cross-sectional study with the use of a structured questionnaire among 38 patients with Crohn's disease and 30 with ulcerative colitis was conducted. The inflammatory bowel disease questionnaire (IBDQ-32) was used to evaluate the patients' quality of life, and the Depression, Anxiety, Stress Scale (DASS21) was used to evaluate these psychological factors. Pearson descriptive statistics and multiple regression analyses were performed. Results According to the findings of the multiple regression analysis, depressive, anxiety, and stress symptoms were negatively associated with quality of life. Participants with higher scores of anxiety had inferior QoL in intestinal symptoms (p=0.013) and in systemic symptoms (p=0.013), with higher scores of depression had inferior QoL in emotional function (p<0.001), and higher scores of stress had inferior QoL in the domain of social support (p=0.002). Psychological symptoms of emotional disorders appear to be associated with lower quality of life in IBD patients. Conclusion This study examined levels of depression, anxiety, and stress in Greek patients with IBD, which were associated with lower levels of their quality of life. Interventions to improve QoL in patients with IBD should consider the effect of psychological symptoms.
Keywords: crohn’s disease (cd); inflammatory bowel disease; psychological symptoms; quality of life (qol); ulcerative colitis (uc).
Copyright © 2022, Mitropoulou et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
References
-
- McDowell C, Farooq U, Haseeb M. Treasure Island, FL: StatPearls Publishing; 2022. Inflammatory bowel disease. - PubMed
-
- The IBD interactome: an integrated view of aetiology, pathogenesis and therapy. de Souza HS, Fiocchi C, Iliopoulos D. Nat Rev Gastroenterol Hepatol. 2017;14:739–749. - PubMed
-
- The burden of inflammatory bowel disease on health care utilization and quality of life. Nurmi E, Haapamäki J, Paavilainen E, Rantanen A, Hillilä M, Arkkila P. Scand J Gastroenterol. 2013;48:51–57. - PubMed
-
- Brain-gut interactions in inflammatory bowel disease. Bonaz BL, Bernstein CN. Gastroenterology. 2013;144:36–49. - PubMed
-
- WHOQOL - measuring quality of life. [ Mar; 2022 ];https://www.who.int/tools/whoqol 2022
LinkOut - more resources
Full Text Sources
Medical